Phosphate Diabetes
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Adult Fanconi syndrome
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Impaired exercise tolerance
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Respiratory distress
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Clumsiness - motor delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Increased CSF lactate
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Increased serum lactate
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Motor delay
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Respiratory insufficiency due to muscle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Increased intramyocellular lipid droplets
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cytochrome C oxidase-negative muscle fibers
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Increased hepatocellular lipid droplets
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Drug-Induced Liver Disease
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
<b>Conclusions:</b> Our findings suggest an interaction of long-term exposure to COX inhibitors combined with functional variants of the COX enzymes in the risk of developing DILI.
|
30873208 |
2019 |
Hemophilia A
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Purpose:</b> Congenital hemophilia A and B are bleeding disorders characterized by deficiency of factors VIII and IX, respectively.
|
31354248 |
2019 |
Cerebral Aneurysm
|
0.020 |
Biomarker
|
disease |
BEFREE |
<b>Purpose:</b> Cerebral aneurysms that compress cranial nerve VIII can cause hearing loss and imbalance.
|
31793349 |
2019 |
Tumor Cell Invasion
|
0.090 |
GeneticVariation
|
phenotype |
BEFREE |
<i>COX-2</i> gene methylation was significantly associated with the depth of invasion (P = 0.003), lymph node metastasis (P = 0.009), distant metastasis (P = 0.036), and TNM staging (P = 0.007).
|
30079321 |
2018 |
Secondary malignant neoplasm of lymph node
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
<i>COX-2</i> gene methylation was significantly associated with the depth of invasion (P = 0.003), lymph node metastasis (P = 0.009), distant metastasis (P = 0.036), and TNM staging (P = 0.007).
|
30079321 |
2018 |
Neoplasm Metastasis
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
<i>COX-2</i> gene methylation was significantly associated with the depth of invasion (P = 0.003), lymph node metastasis (P = 0.009), distant metastasis (P = 0.036), and TNM staging (P = 0.007).
|
30079321 |
2018 |
Mild hereditary factor VIII deficiency disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
3' end of exon 14 of F VIII gene from a mild hemophilia A patient of Chinese origin was amplified by polymerase chain reaction (PCR) and identified mutations by denaturing gradient gel electrophoresis (DGGE) combining with direct sequencing.
|
9594277 |
1997 |
Colorectal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
5-ASA also inhibits the growth of DLD-1, a COX-deficient CRC cell line, thus suggesting that the anti-proliferative effect of 5-ASA on CRC cells is not strictly dependent on the inhibition of COX-2/PGE2.
|
17981262 |
2008 |
Severe hereditary factor VIII deficiency disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
92 out of 111 HA patients (F VIII activity < 1%) were suffering from severe HA.
|
11246535 |
2001 |
Factor 8 deficiency, acquired
|
0.100 |
Biomarker
|
disease |
BEFREE |
: Acquired hemophilia A (AHA) is a rare bleeding disorder caused by the development of autoantibodies against clotting factor VIII.
|
30864964 |
2019 |
von Willebrand Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
: Men and boys who present with bleeding associated with low factor VIII levels and normal von Willebrand studies are assumed to have hemophilia A until proven otherwise.
|
30036281 |
2018 |